News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,901 Results
Type
Article (49682)
Company Profile (278)
Press Release (683941)
Section
Business (212263)
Career Advice (2098)
Deals (36531)
Drug Delivery (103)
Drug Development (83603)
Employer Resources (173)
FDA (16959)
Job Trends (15706)
News (359192)
Policy (34662)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2774)
Accelerated approval (2)
Adcomms (23)
Allergies (83)
Alliances (51548)
ALS (87)
Alzheimer's disease (1415)
Antibody-drug conjugate (ADC) (113)
Approvals (16957)
Artificial intelligence (252)
Autoimmune disease (17)
Automation (14)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (191)
Bladder cancer (60)
Brain cancer (25)
Breast cancer (260)
Cancer (2058)
Cardiovascular disease (172)
Career advice (1758)
Career pathing (30)
CAR-T (142)
Cell therapy (401)
Cervical cancer (21)
Clinical research (67651)
Collaboration (792)
Compensation (458)
Complete response letters (21)
COVID-19 (2708)
CRISPR (36)
C-suite (221)
Cystic fibrosis (99)
Data (1989)
Decentralized trials (2)
Denatured (26)
Depression (45)
Diabetes (256)
Diagnostics (6547)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (113)
Drug pricing (102)
Drug shortages (28)
Duchenne muscular dystrophy (87)
Earnings (88354)
Editorial (34)
Employer branding (21)
Employer resources (147)
Events (116686)
Executive appointments (663)
FDA (18111)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (708)
Gene editing (100)
Generative AI (24)
Gene therapy (284)
GLP-1 (737)
Government (4651)
Grass and pollen (4)
Guidances (48)
Healthcare (19896)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (107)
Indications (27)
Infectious disease (2845)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (87)
Interviews (319)
IPO (16852)
IRA (41)
Job creations (4043)
Job search strategy (1501)
Kidney cancer (9)
Labor market (34)
Layoffs (472)
Leadership (16)
Legal (8455)
Liver cancer (73)
Lung cancer (301)
Lymphoma (135)
Machine learning (4)
Management (58)
Manufacturing (273)
MASH (64)
Medical device (14326)
Medtech (14331)
Mergers & acquisitions (20159)
Metabolic disorders (668)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (28)
Neuroscience (1918)
NextGen: Class of 2025 (6911)
Non-profit (4736)
Northern California (2449)
Now hiring (37)
Obesity (363)
Opinion (215)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (77)
Parkinson's disease (139)
Partnered (20)
Patents (206)
Patient recruitment (95)
Peanut (48)
People (59952)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21043)
Phase II (29726)
Phase III (22221)
Pipeline (1051)
Podcasts (58)
Policy (116)
Postmarket research (2741)
Preclinical (8941)
Press Release (67)
Prostate cancer (97)
Psychedelics (32)
Radiopharmaceuticals (254)
Rare diseases (368)
Real estate (6297)
Recruiting (65)
Regulatory (23570)
Reports (46)
Research institute (2480)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (4)
RSV (41)
Schizophrenia (71)
Series A (121)
Series B (80)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2128)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3826)
State (2)
Stomach cancer (14)
Supply chain (62)
The Weekly (30)
United States (21710)
Vaccines (696)
Venture capitalists (38)
Webinars (12)
Weight loss (251)
Women's health (36)
Worklife (15)
Date
Today (143)
Last 7 days (740)
Last 30 days (2830)
Last 365 days (34391)
2025 (8337)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (794)
Alabama (50)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (40878)
Australia (6738)
California (5600)
Canada (1885)
China (492)
Colorado (258)
Connecticut (272)
Delaware (131)
Europe (88486)
Florida (829)
Georgia (202)
Idaho (61)
Illinois (538)
India (23)
Indiana (297)
Iowa (9)
Japan (143)
Kansas (103)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (870)
Massachusetts (4271)
Michigan (215)
Minnesota (385)
Mississippi (2)
Missouri (79)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (67)
New Jersey (1615)
New Mexico (29)
New York (1617)
North Carolina (986)
North Dakota (7)
Northern California (2449)
Ohio (193)
Oklahoma (14)
Oregon (34)
Pennsylvania (1267)
Puerto Rico (9)
Rhode Island (28)
South America (1183)
South Carolina (19)
South Dakota (1)
Southern California (2128)
Tennessee (95)
Texas (841)
Utah (168)
Virginia (135)
Washington D.C. (61)
Washington State (531)
West Virginia (3)
Wisconsin (50)
733,901 Results for "isoray medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.
GT Medical Technologies, Inc. (GT MedTech) announces the successful acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc.
April 15, 2024
·
5 min read
Deals
GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.
GT Medical Technologies, Inc. (“GT Medical Technologies”), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced it has agreed to acquire substantially all of the radioactive Cesium-131 seed assets and related business infrastructure from Isoray Medical, which is a subsidiary of Perspective Therapeutics, Inc. (“Isoray”).
December 12, 2023
·
6 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
April 1, 2025
·
1 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
March 6, 2025
·
1 min read
Press Releases
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
March 10, 2025
·
2 min read
Press Releases
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
February 26, 2025
·
29 min read
Press Releases
Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting
February 20, 2025
·
3 min read
Press Releases
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 21, 2025
March 24, 2025
·
3 min read
BioForest
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT
Isoray Medical, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, and Viewpoint Molecular Targeting, Inc., a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced they will hold an investor webcast Wednesday, October 19, 2022, at 4:15 p.m. EDT.
October 18, 2022
·
5 min read
Press Releases
AI/ML Innovations Inc. Appoints Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships
January 27, 2025
·
3 min read
1 of 73,391
Next
